chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a physician and described the occurrence of bruise injection site in a 4-year-old female subject who was vaccinated with combined KINRIX, (GlaxoSmithKline).  The subject had no relevant medical history, and had experienced no adverse events following previous vaccinations.  There were no concomitant medications.  Concurrent vaccination included MMR II (non-gsk) (Merck) given on 9 April 2009 and VARIVAX (non-gsk) (Merck) given on 9 April 2009.  On 9 April 2009 at 15:00 the subject received 2 doses of KINRIX (0.5 ml, unknown route), one in the left leg and one in the right leg (overdose).  The order of the vaccinations was not specified.  On 9 April 2009, immediately after vaccination with KINRIX, the subject experienced bruising at both injection sites.  On 9 April 2009, the events were resolved.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 18-SEP-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 ten 0.5ml single-dose vial (SDV) (lot # K019561, expiration date 20-APR-2016). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the highest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 24, 47 and R; 112, 49 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
pain in the arm, and that it was hot with fever, after the first dose of the vaccine.; pain in the arm, and that it was hot with fever, after the first dose of the vaccine.; pain in the arm, and that it was hot with fever, after the first dose of the vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm, and that it was hot with fever, after the first dose of the vaccine.), FEELING HOT (pain in the arm, and that it was hot with fever, after the first dose of the vaccine.) and PYREXIA (pain in the arm, and that it was hot with fever, after the first dose of the vaccine.) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in the arm, and that it was hot with fever, after the first dose of the vaccine.), FEELING HOT (pain in the arm, and that it was hot with fever, after the first dose of the vaccine.) and PYREXIA (pain in the arm, and that it was hot with fever, after the first dose of the vaccine.). At the time of the report, PAIN IN EXTREMITY (pain in the arm, and that it was hot with fever, after the first dose of the vaccine.), FEELING HOT (pain in the arm, and that it was hot with fever, after the first dose of the vaccine.) and PYREXIA (pain in the arm, and that it was hot with fever, after the first dose of the vaccine.) outcome was unknown.            Concomitant product use was unknown by the reporter. No Treatment information was provided for the event. Action taken with mRNA-123 was not applicable.   This case was linked to MOD-2021-028157 (Patient Link).   Reporter did not allow further contact
pt recvd vax; approx 24 hrs later,broke out in hives on chest,arms & legs;also low grade t; tsxs lasted  48 hrs;
Dizziness and nausea 10 minutes after injection, continued to wax and wane over approx 90 minutes.  No vitals taken.  Patient ambulated back to work at 1800.
ZOSTER, papules, start from R buttock and going down the leg.  Also had a fever for a few days.  Rash was slightly itchy.
This case was reported by a physician and described the occurrence of pain in arm in a adult patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm, erythema of extremities, swelling arm and skin warm. On an unknown date, the outcome of the pain in arm, erythema of extremities, swelling arm and skin warm were recovered/resolved. It was unknown if the reporter considered the pain in arm, erythema of extremities, swelling arm and skin warm to be related to SHINGRIX. Additional details were provided as follows: This case was created for the patient in reporter's building. The age at vaccination was not reported. The events were resolved in several days. The reporter believed it was local reaction to the medication. This was 1 of 4 cases, reported by same reporter.
Petechial rash both legs developed day 13/14 days after smallpox vacccination. Major reaction healing well right upper arm. No systemic symptoms. Back to work 02/18/03 (next duty day).
About one hour after receiving the vaccine, my tongue went numb for about 12 hours. I had taste and smell, but tongue was numb.
numbness and tingling in my face, neck and ears; numbness and tingling in my face, neck and ears; Weakness in left side of body; Chest pain; Metallic taste in my mouth; Headache; Body ache; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 11Apr2021 at 15:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune diseases, mixed connective tissue disease, lymphocytic colitis, B12 and folate deficiencies, fibromyalgia, depression and anxiety. The patient was allergic to penicillin. The patient received unspecified concomitant medications within two weeks of vaccination. The patient previously took codeine and vicodin and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 15:15, within about 5 minutes after the vaccine, the patient experienced weird metallic taste in her mouth. On 11Apr2021 at 15:20, about 5 minutes after that, the patient experienced numbness and tingling in her face, neck and ears and her whole left side of the body became weak and she had chest pains. Emergency Medical Technicians (EMTs) came over and checked her vitals a few times. On the same day, the patient slept for 5 hours and then had a horrible headache and her entire body ached. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events metallic taste in mouth, numbness and tingling in face, neck and ears, whole left side of the body became weak, chest pains, headache and body ache were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Pt has been having dizziness, headaches, and an episode of unconsciousness 1 day post vaccination. He has had possible absence seizures with it. Has continued to be dizzy and have headaches since then. We are investigating further with labs and imaging but at this time have not done any treatment.
Information has been received from a registered nurse concerning a 6 year old male on 19-JAN-2001 was vaccinated with a first dose of Varivax. The registered nurse reported that the patient's mother called the office to report that the patient developed chicken pox after in school exposure. The patient was seen in the office on 21-DEC-2006 and diagnosed with with enterovirus versus dermatitis. The patient presented with pinpoint rash over the body after a bath. There were 25-30 spots with central whiteheads and reddening around them. The outcome was reported as recovered. Additional information has been requested. This is in follow-up to report (s) perviously submitted on 5-16/2007.
Erythematous blanching maculopapular rash affecting face, trunk, arms and legs with most intense erythema at site of vaccine administration, left upper arm
Sore arm last for 4 days upon administration of vaccine.  Have experienced ongoing hyper-sensitivity to smells/odors since shot administration which have led to nausea.  Hyper-sensitivity is ongoing.
Pharmacist gave too high on arm (almost shoulder area). Patient reported immediate numbness and loss of strength in arm. He did take 400mg Ibuprofen to help with swelling in area and stated that it did help. Today patient states his arm is doing better, but still lacking strength. Will follow up in a few days to assess if further medical attention is needed.
This spontaneous report was received from a nurse concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported.  On 24-MAY-2017, the patient was vaccinated with an expired dose of M-M-R II rHA, lot # L015282, expiration date: 30-APR-2017, as prophylaxis (strength, dose and route were not reported). No adverse effects were reported.    Additional information has been requested.
I became lightheaded and felt like I was going to faint. It lasted about 30 minutes to an hour then I was really tired after that. The next day, I went to see Dr. and she did an EKG which was normal except I had bradycardia. Everything else was normal, labs were normal. EKG was otherwise normal. I'm going to get a cardiac monitor next week and have an echocardiogram next week. Since then, I have just brief periods of lightheadedness. They're brief and mild and they don't last like the initial one did.
Information was received from a registered nurse regarding a 16 year old male patient. On an unknown date, about 2 months ago, the patient received his second dose of GARDASIL, 0.5 ml (route of administration not provided). After receiving the vaccine, the patient stood up and fainted. He hit his head on the wall, but had no concussion, no "problems" following fainting and did not need any follow-up. The patient was told to sit, and was then allowed to go. The patient recovered from the event. Additional information is not expected.
injection site felt warm; fever; fatigue; redness at injection site; pain in arm/injection site pain; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (received 1st dose on 9th February 2020, refer case US2020AMR123816). Concomitant products included acyclovir.   On 3rd July 2020, the patient received the 2nd dose of Shingrix. On 3rd July 2020, less than a day after receiving Shingrix, the patient experienced injection site warmth, fever, fatigue and injection site erythema. In July 2020, the patient experienced pain in arm. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm, injection site warmth, fever, fatigue and injection site erythema were unknown.   It was unknown if the reporter considered the pain in arm, injection site warmth, fever, fatigue and injection site erythema to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and felt fatigue, redness at injection site, pain at injection site, injection site warmth and a sore arm. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR123816:same reporter
Little headache; Sneezing; Runny Nose; This is a spontaneous report received from a contactable physician (Patient reported for herself). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration on 05Mar2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications. Patient stated she took first dose on 05Mar2021. In Mar2021 She has something in her arm and a little headache. The next day, her arm was getting better. After 2 days all were normal. Then in two days, which would be 5th day, she began having sneezing and runny nose for 2 days. This is not a common symptom that people who take the vaccine experience. She would like to know if this is something serious and if she should go to the doctor. The outcome of the event headache was reported as recovered on Mar2021 and while other events was unknown.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
Supraclavicular adenopathy - 5-6 palpable nodes. Still present >24 hours later.
09/16/22 presents to ED for "Motor Vehicle Crash". PMHx of chronic neck pain."
Swelling, redness and pain ~4x6" to Left arm. Advise in use of cold compresses, ibuprofen 400 q 46 h, Benadryl 50mg q hr
Two days after pt. received ZOSTAVAX vaccine, she came in and had large red circle at injection site and it was warm to touch.
The patient presents with symptoms that started immediately after pt received her first covid vaccine around 1000 today at center.  she developed lightheadedness, sob, nausea, h/a, and when er triage nurse was triaging her she syncopized for 3-4 seconds. no fall. pt was seated.  and pt also reports that earlier she felt like the room was spinning.     Tx in the ED w zofran and discharged.
Within one week after my 1st dose, my tinnitus had reached extreme levels and over the next several weeks, I lost the rest of my hearing to the point now of being profoundly deaf. I no longer wear hearing aids (as mentioned a few pages ago), as they are no longer useful since losing the rest of my hearing. After the 1st dose, my tinnitus (that I previously had), became extremely loud (it was louder than it's ever been), and my hearing loss progressed then extremely fast (after the 1st dose), to the point of profound deafness. Diagnosed as sensorineural hearing loss.
Pregnant; Tested positive for covid; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) and SARS-COV-2 TEST POSITIVE (Tested positive for covid) in a 38-year-old female patient (gravida 2, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 22-Jun-2020 and the estimated date of delivery was 29-Mar-2021. On 09-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) and SARS-COV-2 TEST POSITIVE (Tested positive for covid). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-eighth week of the pregnancy. The delivery occurred  on 30-Mar-2021, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 09-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for covid) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, COVID-19: positive (Positive) positive. On 06-Jul-2021, Pregnancy test: positive (Positive) Tested positive on 13 Jan 2021..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by the reporter. Past pregnancy data included: Live birth, no complications delivered at 41 weeks. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: follow up received and contains EDD date ,delivery date
After administering a flu vaccination, the needle did not extract into the safety device and my left thumb was pricked as I inserted the syringe into the Sharps container.
8 hours after the shot= all my joints hurt. Joints that normally do not hurt did like my neck joint, right wrist joint. The joints that do normally hurt were way worse (my back, and right big toe joint). There was a pain in my right eye, and that eye had blood vessels burst in it.  36 hours after the shot= started bleeding from my vagina. My last menstruation was 2 weeks ago and this is VERY unusual for me. Normally my periods are 30-32 days apart.
my arm is very red and slightly; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (my arm is very red and slightly) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included Redness (arm is very red and slightly).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (my arm is very red and slightly). At the time of the report, ERYTHEMA (my arm is very red and slightly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication not reported.  Treatment medication not reported.
This medication was administered at about 10:23 am on Sunday 4-11-21.  The vial from which it was administered from was first punctured and removed from the refrigerator at 2:35pm on Saturday 4-10-21.  Therefore,  the vial had been first removed from the refrigerator and punctured about 20 hours before the patient received the vaccine.  It was outside of the current 12 hour range.
Took the new shingles vaccine and have 10 days of severe flu symptoms with inability to work for several days. Began one day after vaccine. My wife took vaccine at same time and had similar protracted flu and bronchitis.
Light headed, nausea, rash on face and neck. Red blotching on back and anterior chest. Left arm discomfort and pruritis. Redness around Hep A injection site. Close observation and monitoring of vital signs.
Seven weeks after receiving his 2nd booster (#4 in series), my father had a massive stroke and passed away.  He had no previous history of stroke, clots, or even headaches.
81 vaccines that were improperly cooled; arm was barely sore; This is a spontaneous report received from a contactable consumer (Patient's husband). This consumer reported for a 72-year-old female patient (wife) that. A 72-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: EZ9269) via an unspecified route of administration on 15Feb2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that caller explained he was calling on behalf of his 72-year-old wife who received the first dose of the Pfizer-BioNTech COVID-19 on 15Feb2021. He added it was reported on the news that 81 of the vaccinated people at that location inadvertently received vaccines that were unproperly cooled, and they will get notify for revaccination. He mentioned he was trying to figure out if his wife was part of the 81 individuals who need be revaccinated and asked if we had information. He said that they have not heard anything yet, but he wants to make sure that she did not receive one of the vaccines involved. He explained he called a COVID-19 Vaccination Hotline and they were not able to further assist. He then added his wife's arm was barely sore after the first dose i.e Feb2021 and she was scheduled to receive the second dose on 8Mar2021. Caller further asked if a low reaction, or no reaction to the Pfizer-BioNTech COVID-19 vaccine implies there was no immune response to it. Outcome of event arm was barely sore was unknown.  No follow-up attempts are possible. No further information is expected.
Within 10 minutes of receiving his immunizations he lost consciousness and his hands/arms were shaking with his hands in a "clonic" position. Episode lasted less than 30 sec. - witnessed by RN and LVN.
Pt had flu shot & within 3 hrs felt chest tightness & dyspnea proceeded to have nausea later in the day (8 hours later) and at HS same day had fever & chills - the next day had lingering nausea & dyspnea. Day 3 she felt "fine" - no tx sought - pt called with these symptoms.
PT HAD A LOCAL REACTION ON HIS OUTER LEFT ARM. PT COMPLAINED OF BURNING AND ITCHING. THERE WAS NO AIRWAY COMPROMISE. PT WAS MONITORED FOR 45 MIN AND WAS SENT HOME WITH COLD COMPRESS AND TYLENOL. PT RETURNED TO CLINIC A WEEK LATER WITH A SLIGHT REACTION STILL ON OUTER LEFT ARM AND WAS GIVEN BENADRYL.
No adverse symptoms. Patient received the wrong dosage. Patient was suppose to receive a monovalent primary dose and received a bivalent booster.
Vaccine 12/9/09 - within 2 days complained of neck pain and by 12/20 started to have involuntary head movements which became more severe by 12/25/09. Seen in the emergency room and then pediatricians 12/26 who diagnosed her with a tic. Follow-up: Added note: After the tic, she has now developed possible seizures. Neurological work-up in progress as well as cardiology work-up. Syncopal episode 2/3/10 and again 2/5/10.
Was given IMZ on 7/30/17. On 8/2/17 she felt "pain all over, all the way down to her finger tips". Then she woke up on 8/6/17 with her immunized arm hot, swollen and very red, and a bit itchy.  When asked if she had a fever, she responded "not much".
Shingles developed at injection site and down left arm to fingers.  First symptoms (pain in upper left arm) on 3/31/21. Shingles rash developed  nine days later. Visit to Dr. confirmed shingles diagnosis on 4/9/21  Enlarged lymph node developed in right side of neck two weeks after second vaccine. Resolved in 5 days,
NONE GIVEN EXIPIRED COVID 19 : EXPIRED 11/22/22 GIVEN ON 12/19/22
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patients' concurrent condition and medical history were not provided. On 29-MAR-2016 the patient was vaccinated with improperly stored (Merck) VARIVAX (lot # L019125, exp.: 27-MAY-2017) (dose, route and site of administration not reported). Concomitant medication was not mentioned. The vaccine was stored at 12F for a time frame of 20 minutes daily for 140 days (incorrect product storage). The call was a result of a data logger. There was no previous temperature excursion reported. No adverse effects reported. No further information was provided. Product quality complaint was not filed. Additional information has been requested. This is one of the four reports received from the same reporter.
I experienced months afterwards of my vaccine, I had a major heart attack on the end of January 2023. I experienced headaches, cognitive fatigue and traumatic brain injury. I had many blood work and MRI and CT scans. I have not recovered from my symptoms.  I do  not know if the heart attack is connected with my vaccine.
Mom phoned for ambulance around 5:30pm due to sudden onset of seizure like activity while in store. No recent fever or illness reported but had immunizations on 08/23/2018. Infant was transported to hospital. CT without contrast was done with Impression being Normal CT head. Placed on cardiac monitor, IV started and ATIVAN given. Option given to admit or transfer to MC. Transferred to MC via non-emergent ambulance. Admitted on 08/24/2018 to MC, EEG and MRI of the brain done. The etiology of the seizure like activity was unclear. He was referred to see Neurology in 4-6 weeks and PCP in about 1 week. Discharged from MC on 08/25/2018.
Hives, relieved by Benadryl. Pt undergoing allg testing.